Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Enhanced transgene expression and processing

A transgenic and gene technology, applied in the field of recombinant mammalian cell preparation, can solve the problem of not improving the efficiency of alkaline phosphatase protein secretion and the like

Pending Publication Date: 2015-11-18
SELEXIS SA
View PDF10 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, for example, Lakkaraju et al. (2008) reported that expression of exogenous SRP14 in wild-type human cells (e.g., in cells that have not been engineered to express low levels of SRP14) did not enhance secretion of the secreted alkaline phosphatase protein efficiency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enhanced transgene expression and processing
  • Enhanced transgene expression and processing
  • Enhanced transgene expression and processing

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0165] A transgene as used in the context of the present invention is an isolated isolated functional RNA (non-coding RNA) that encodes a given mature protein (also referred to herein as protein-encoding DNA), a precursor protein, or does not encode a protein. Deoxyribonucleotide (DNA) sequence. The transgene is isolated and introduced into cells to produce a transgene product. Some preferred transgenes according to the invention are those encoding immunoglobulin (Ig) and Fc fusion proteins and other proteins, especially proteins with therapeutic activity ("biotherapeutics"). For example, certain immunoglobulins such as Infliximab (Remicade) or other secreted proteins such as coagulation factor VIII are particularly difficult to express due to largely uncharacterized cellular bottlenecks. These bottlenecks can be identified and / or opened with the aid of the recombinant nucleic acid molecules, vectors and methods of the invention. This generally increases the amount of therap...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed are constructs and methods for expressing DNAs of interest in particular in non- primate eukaryotic host cells that display advantages with regard quantity and quality of expression including high stability of expression and, if appropriate, transport of the expression product out of the cell.

Description

technical field [0001] The present invention relates to the provision of nucleic acid constructs and proteins involved in or acting on metabolic pathways that mediate or affect cellular metabolism, such as translocation across the ER membrane and / or translocation across the plasma membrane, and methods of affecting cellular metabolism. secretion. The invention also relates to the preparation and use of recombinant mammalian cells in which, for example, the translocation / secretion of diverse heterologous proteins (transgene expression products) is altered. The methods, nucleic acid constructs are generally designed to enhance transgene expression. Background technique [0002] The biotechnological production of therapeutic proteins and gene and cell therapies depends on the introduction of successful transgene expression into eukaryotic cells. Successful transgene expression generally requires integration of the transgene into the host chromosome and is particularly limited...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/90C12N15/85C07K16/00
CPCC12N15/85C07K16/00C07K16/241C07K16/32C12N15/90C12N2800/107C12N2800/90C12N2830/46C07K2317/10C07K2317/24
Inventor V·勒富尔N·梅尔莫A·雷加梅M·巴赛特D·莱伊N·哈拉奇K·科斯特拉科P-A·吉拉D·卡拉布列兹
Owner SELEXIS SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products